Category: SeaPRwire

New York, NY – August 28, 2025 – (SeaPRwire) – As part of its launch, Poolbetx (https://poolbetx.com) proudly introduces its Token (PBX), a stable crypto coin designed as a digital igaming chip for the Poolbetx ecosystem. Built on TON Blockchain: PBX runs on the highly scalable TON blockchain, ensuring speed, low fees, and reliability. Global Accessibility: PBX can be accessed and traded across all major DEX pools including DeDust.io and Ston.fi. Wallet Integration: Customers can easily buy, exchange, or cash out PBX tokens directly through Telegram Wallet and TON Hub Wallet, available on the Apple App Store and Google Play Store. Borderless & Jurisdiction-Free: PBX enables seamless global usage, allowing Poolbetx players to withdraw, play, and transact without jurisdictional restrictions – a world-first innovation in crypto igaming platforms. “PBX is more than a token – it’s a bridge between our global customers and the Poolbetx ecosystem,” said a Poolbetx spokesperson. “By making PBX accessible on everyday apps like Telegram and Tonhub, we’re ensuring anyone, anywhere, can join Poolbetx with ease.” With PBX, Poolbetx not only provides premium i- games but also a financial infrastructure that redefines global access to entertainment. Related Links Telegram: https://t.me/poolbetx PBX on DeDust: https://dedust.io/ PBX on Stonfi: https://ston.fi/ Media contact Brand: Poolbetx Contact: media team Email: support@poolbetx.com Website: https://poolbetx.com

New York, NY – August 27, 2025 – (SeaPRwire) – T-RIZE Group, a global fintech firm offering institutional-grade tokenization infrastructure, is launching Vision 60 by Ste-Rose, a $24.2 million, 60-unit energy-efficient residential development in Laval, Québec. This project is part of a 500+ unit new construction deal with T-RIZE Group, valued at $200 million. Tokenized by T-RIZE, the offering is being launched through a strategic collaboration with Republic, one of the world’s leading regulated investment platforms with over 3 million users, $3 billion in deployed capital, and more than 2,500 ventures backed. Accredited investors will be able to participate using both fiat and cryptocurrency. Pipeline Execution in Motion Vision 60 by Ste-Rose follows Vision 87 by Champfleury, an 87-unit, $23 million tokenized offering that forms part of a separate $300 million, 956-unit residential development. Together, these offerings reflect the ongoing execution of T-RIZE’s multi-billion-dollar pipeline, applying a scalable, compliant framework for bringing real-world assets onchain. T-RIZE leads tokenization, including asset digitization, legal structuring, and smart contract deployment. Republic’s affiliate broker-dealer, OpenDeal Broker LLC , Member FINRA & SiPC, oversees investor onboarding and distribution under Regulation D. Token-Powered Infrastructure Vision 60 will be deployed on an EVM-compatible blockchain such as Base or Avalanche, two leading infrastructures supporting institutional adoption of real-world assets. Base, incubated by Coinbase, enables low-cost execution, robust security, and seamless integration with Ethereum and capital markets ecosystems, offering a strong foundation for tokenized financial products. Avalanche delivers high-performance infrastructure with flexible tooling, supporting regulatory alignment and scalable deployment of institutional tokenization use cases. The $RIZE utility token anchors the T-RIZE ecosystem. It is used to access and pay for tokenization services—including onboarding, structuring, and listing—while also unlocking vetted investment opportunities, enabling decentralized governance, and supporting ecosystem growth. With 30% of supply allocated to governance and incentives, $RIZE is listed on tier-1 venues like Kraken and Revolut. Built with Institutional-Grade Standards Vision 60 is supported by a network of third-party experts and institutions: ● Ekitas – Legal and tax structuring ● CBRE – Independent project appraisal ● BDO – Return and cash flow projections ● Intact Insurance – Performance bond underwriting ● MA2D – Lead developer ● Concept Habitation Duo Inc. – Property manager ● Republic – Regulated global investment platform T-RIZE also operates as a validator and RWA issuer on the Canton Network, a privacy-first blockchain used by institutions such as Goldman Sachs, Broadridge, and Cumberland, where over $2 trillion in monthly transactions are settled and more than $4 trillion in digital assets are safeguarded. This positions T-RIZE at the intersection of regulated finance and onchain innovation. “Tokenized real estate is no longer a concept—it’s entering its institutional growth phase,” said Madani Boukalba, CEO of T-RIZE Group. “Vision 60 is a real-world proof point of how scalable, compliant infrastructure unlocks global access to tokenized real estate—setting the stage for broader institutional adoption.” About Republic Headquartered in New York City, Republic is a global financial firm operating a network of retail-focused investment platforms and an enterprise digital advisory arm. With a deep track record of legal and technical innovation, Republic is known for providing access to new asset classes to investors of all types. Backed by Valor Equity Partners, Galaxy Interactive, HOF Capital, AngelList and other leading institutions, Republic boasts a global portfolio of over 2,000 companies and a community of nearly three million members in over 150 countries. More than $3 billion has been deployed through investment platforms, funds, and firms within the Republic family of companies with operations established in the US, the UK, EU, the UAE and South Korea. All broker-dealer related securities activity is conducted by OpenDeal Broker LLC, an affiliate of OpenDeal Inc. a registered broker-dealer, and member of FINRA | SiPC, located at 149 5th Avenue, 10th FL, New York, 10010 please check our background on FINRA’s BrokerCheck and Form CRS here. For additional information, visit https://republic.com/ About T-RIZE Group Founded in 2022, T-RIZE is an institutional tokenization platform onboarding a multi-billion-dollar pipeline of real estate, structured financial products, and AI Energy Offset Reserve Notes. The T-RIZE platform transforms these assets into programmable digital instruments that unlock liquidity, lower capital costs, and enhance underwriting and risk modelling while protecting sensitive data through privacy-preserving AI. At its core, the RIZE token powers tokenization services, connects institutions to vetted investments and AI-driven infrastructure, and supports governance and incentive programs across the ecosystem. For more information, visit www.T-RIZE.io or contact: Press Inquiries: press@T-RIZE.io Head Office: 1155 René-Lévesque West, Suite 2500, Montreal, QC H3B 3X7, Canada Toronto Office: 130 King Street West, Suite 1900, Toronto, ON M5X 1E3, Canada

PALM BEACH, FL – August 25, 2025 – (SeaPRwire) – BlackRidge & Co, an elite global advisory firm, announced that it has established its official headquarters in Palm Beach, Florida, as the region cements its reputation as “Wall Street South.” The move places the firm at the center of one of the fastest-growing financial hubs in the United States, with additional offices in New York, Silicon Valley, London, and Hong Kong. To learn more about BlackRidge & Co, visit www.blackridgeandco.com The BlackRidge & Co leadership team brings a heritage of advising the most prestigious institutions, including Rothschild Asset Management, Deutsche Bank, and ICBC Hong Kong. Beyond advisory services, the firm’s specialty is orchestrating introductions to capital, forging strategic growth partnerships, and working alongside clients to unlock new markets and drive long-term value creation. “At BlackRidge & Co, our mission is to create opportunities that are often inaccessible through traditional channels—pairing extraordinary companies with the investors and capital they need to scale globally,” said Director of Communications, Isaac Meyer. The migration of capital and talent into South Florida has reshaped the financial landscape. Since Ken Griffin’s Citadel relocated from Chicago to Miami in 2022, major institutions including Goldman Sachs, Blackstone, and Peter Thiel’s Founders Fund have followed, creating a powerful concentration of wealth and influence. Palm Beach has emerged as the crown jewel of this movement, now home to more than 300 hedge funds, private equity firms, and financial institutions. A 2025 Forbes analysis reports that at least 68 billionaires maintain strong ties to Palm Beach, underscoring its position as a magnet for global wealth. About BlackRidge & Co BlackRidge & Co is a global advisory firm headquartered in Palm Beach with hubs in New York, Silicon Valley, London, and Hong Kong. The firm specializes in capital introductions, connecting visionary companies with the world’s most influential financiers, investors, and lenders. Through cultivated relationships and decades of experience, BlackRidge helps clients unlock new opportunities, build partnerships, and create sustainable growth. Media contact Brand: BlackRidge & Co Contact: Isaac Meyer, Director of Communications E-mail: im@blackridgeandco.com Website: https://www.blackridgeandco.com

PALM BEACH, FL – August 25, 2025 – (SeaPRwire) – BlackRidge & Co, an elite global advisory firm, announced that it has established its official headquarters in Palm Beach, Florida, as the region cements its reputation as “Wall Street South.” The move places the firm at the center of one of the fastest-growing financial hubs in the United States, with additional offices in New York, Silicon Valley, London, and Hong Kong. To learn more about BlackRidge & Co, visit www.blackridgeandco.com The BlackRidge & Co leadership team brings a heritage of advising the most prestigious institutions, including Rothschild Asset Management, Deutsche Bank, and ICBC Hong Kong. Beyond advisory services, the firm’s specialty is orchestrating introductions to capital, forging strategic growth partnerships, and working alongside clients to unlock new markets and drive long-term value creation. “At BlackRidge & Co, our mission is to create opportunities that are often inaccessible through traditional channels—pairing extraordinary companies with the investors and capital they need to scale globally,” said Director of Communications, Isaac Meyer. The migration of capital and talent into South Florida has reshaped the financial landscape. Since Ken Griffin’s Citadel relocated from Chicago to Miami in 2022, major institutions including Goldman Sachs, Blackstone, and Peter Thiel’s Founders Fund have followed, creating a powerful concentration of wealth and influence. Palm Beach has emerged as the crown jewel of this movement, now home to more than 300 hedge funds, private equity firms, and financial institutions. A 2025 Forbes analysis reports that at least 68 billionaires maintain strong ties to Palm Beach, underscoring its position as a magnet for global wealth. About BlackRidge & Co BlackRidge & Co is a global advisory firm headquartered in Palm Beach with hubs in New York, Silicon Valley, London, and Hong Kong. The firm specializes in capital introductions, connecting visionary companies with the world’s most influential financiers, investors, and lenders. Through cultivated relationships and decades of experience, BlackRidge helps clients unlock new opportunities, build partnerships, and create sustainable growth. Media contact Brand: BlackRidge & Co Contact: Isaac Meyer, Director of Communications E-mail: im@blackridgeandco.com Website: https://www.blackridgeandco.com

Hunet Plus Co., Ltd. (CEO Hyukjin Cha), a company specializing in next-generation semiconductor and display materials, announced on Aug. 13th that it has secured Pre-Series B investment for entry into the U.S. market from global semiconductor-related companies, including strategic investors from Japan and Taiwan, as well as the Korean financial investor, ANDA Asia Ventures. In particular, this investment – secured at a time when US and Korea’s tariff issues in the semiconductor sector are coming to the forefront – marks a significant milestone, as it has attracted investment from leading investors from Korea, Japan, and Taiwan. The deal is expected to provide strong momentum not only for securing the original technology of ML-EUV® (Molecular Layer Assembled Extreme UltraViolet Technology, Process and Materials – a multilayer molecular film vacuum process-type photoresist for extreme ultraviolet lithography), but also for obtaining international patents to support market entry into the U.S., Japan and global markets. Furthermore, as one of the few Korean start-up companies to successfully attract foreign investment from Japan and Taiwan, Hunet Plus is expected to gain strong traction in expanding its markets while strengthening its global competitiveness. ML-EUV® is a next-generation total solution for EUV (Extreme Ultraviolet) lithography, encompassing vertically stacked molecular structures, manufacturing processes, and materials. Hunet Plus’ ML-EUV® has overcome the limitations of achieving ultra-high resolution (below 10 nm line width) and sub-2 nm line edge roughness (LER), which have been difficult to realize with existing methods such as: Second-generation chemical amplification resists (wet process, Chemical Amplification Resist) Third-generation inorganic nano-cluster-based resists (wet process, Nano Cluster Based Resist) Fourth-generation inorganic dry-process resists (dry process, Inorganic Precursor Resist) Hunet Plus’ ML-EUV® achieves world-class performance of ultra-high resolution below 10 nm and line edge roughness below 2 nm by using organic precursors and inorganic precursors at the molecular level, forming 10–20 nm ultra-thin multi-layered resist films through its proprietary Organic–Inorganic Molecular Layer Deposition Process® – an innovative dry molecular-layer stacking method. Through this strategic investment, Hunet Plus has formally launched commercialization efforts for ML-EUV®. Based on the world’s highest-performing ML-EUV®, the company plans to jointly commercialize ML-EUV® equipment and processes for dry processing with leading global semiconductor equipment manufacturers, while also supplying core organic and inorganic process materials for ML-EUV®-related semiconductor processes in partnership with global materials companies. In doing so, Hunet Plus aims to position itself as a key player in the semiconductor materials, components, and equipment sector. Hyukjin Cha, CEO of Hunet Plus, stated: “In the global semiconductor market, national borders no longer matter. In the near future, technologies and products like our ML-EUV® – innovative and market-leading – will be the basis for global companies to collaborate and build ecosystems that dominate the market and ensure sustainability. We anticipate additional USD 10 Million follow-on investments from our existing shareholders as well as other global companies, including in the U.S., and will work with local clients to build unique and sustainable ecosystem.” Haesun Kim, Senior Executive Director of HunetPlus, who played a pivotal role in leading the successful domestic and overseas fundraising, drew on more than 25 years of professional experience in international finance and foreign capital attraction, commented: “Although the past two years have been a very challenging period for Hunet Plus – requiring not only navigating detailed and rigorous due diligence imposed by top-tier international investors but also had to lead strategic negotiations – it has been deeply rewarding. In particular, despite a difficult investment climate as well as attracting interest from potential investors to one of the top level industries in the world, this has become a meaningful success story made possible by the organic cooperation with HunetPlus executives.” Cho Namhoon, CEO of K-Ground Ventures, an existing investor and the operator of Scale-Up TIPS who provided behind-the-scenes support for this investment, said: “Even in Korea’s challenging environment for bold investments in original technology, we had a strong belief in Hunet Plus’ global-standard R&D capabilities. Through the Hongneung Advanced Science & Technology Commercialization Fund, we took the bold step of making an early-stage investment, followed by support for subsequent fundraising, reinvestment through the Innovation IP Fund, and additional backing via Scale-Up TIPS. This long-term investment strategy has brought significant results. In particular, the attracting investment from renowned global investors is expected to support U.S. market entry and lead to further follow-on investments, ultimately building a sustainable global supply ecosystem for Korean semiconductor technology through joint Korea–U.S. R&D, production, and marketing.” Meanwhile, on August 6 (local time), U.S. President Donald Trump, at an Apple facility investment announcement event, stated, “We will impose 100% tariffs on every semiconductor imported into the United States.” This announcement has drawn intense attention from semiconductor startups and investors, as semiconductors are the second-largest category of U.S.-bound exports, especially ahead of the upcoming Korea–U.S. summit, where the government’s response will be closely watched. Media contact Brand: Hunet Plus Contact: Hyukjin Cha, CEO Email: support@hunetplus.com Telephone: +82-10-8817-0003 Website: https://en.hunetplus.com

Hunet Plus Co., Ltd. (CEO Hyukjin Cha), a company specializing in next-generation semiconductor and display materials, announced on Aug. 13th that it has secured Pre-Series B investment for entry into the U.S. market from global semiconductor-related companies, including strategic investors from Japan and Taiwan, as well as the Korean financial investor, ANDA Asia Ventures. In particular, this investment – secured at a time when US and Korea’s tariff issues in the semiconductor sector are coming to the forefront – marks a significant milestone, as it has attracted investment from leading investors from Korea, Japan, and Taiwan. The deal is expected to provide strong momentum not only for securing the original technology of ML-EUV® (Molecular Layer Assembled Extreme UltraViolet Technology, Process and Materials – a multilayer molecular film vacuum process-type photoresist for extreme ultraviolet lithography), but also for obtaining international patents to support market entry into the U.S., Japan and global markets. Furthermore, as one of the few Korean start-up companies to successfully attract foreign investment from Japan and Taiwan, Hunet Plus is expected to gain strong traction in expanding its markets while strengthening its global competitiveness. ML-EUV® is a next-generation total solution for EUV (Extreme Ultraviolet) lithography, encompassing vertically stacked molecular structures, manufacturing processes, and materials. Hunet Plus’ ML-EUV® has overcome the limitations of achieving ultra-high resolution (below 10 nm line width) and sub-2 nm line edge roughness (LER), which have been difficult to realize with existing methods such as: Second-generation chemical amplification resists (wet process, Chemical Amplification Resist) Third-generation inorganic nano-cluster-based resists (wet process, Nano Cluster Based Resist) Fourth-generation inorganic dry-process resists (dry process, Inorganic Precursor Resist) Hunet Plus’ ML-EUV® achieves world-class performance of ultra-high resolution below 10 nm and line edge roughness below 2 nm by using organic precursors and inorganic precursors at the molecular level, forming 10–20 nm ultra-thin multi-layered resist films through its proprietary Organic–Inorganic Molecular Layer Deposition Process® – an innovative dry molecular-layer stacking method. Through this strategic investment, Hunet Plus has formally launched commercialization efforts for ML-EUV®. Based on the world’s highest-performing ML-EUV®, the company plans to jointly commercialize ML-EUV® equipment and processes for dry processing with leading global semiconductor equipment manufacturers, while also supplying core organic and inorganic process materials for ML-EUV®-related semiconductor processes in partnership with global materials companies. In doing so, Hunet Plus aims to position itself as a key player in the semiconductor materials, components, and equipment sector. Hyukjin Cha, CEO of Hunet Plus, stated: “In the global semiconductor market, national borders no longer matter. In the near future, technologies and products like our ML-EUV® – innovative and market-leading – will be the basis for global companies to collaborate and build ecosystems that dominate the market and ensure sustainability. We anticipate additional USD 10 Million follow-on investments from our existing shareholders as well as other global companies, including in the U.S., and will work with local clients to build unique and sustainable ecosystem.” Haesun Kim, Senior Executive Director of HunetPlus, who played a pivotal role in leading the successful domestic and overseas fundraising, drew on more than 25 years of professional experience in international finance and foreign capital attraction, commented: “Although the past two years have been a very challenging period for Hunet Plus – requiring not only navigating detailed and rigorous due diligence imposed by top-tier international investors but also had to lead strategic negotiations – it has been deeply rewarding. In particular, despite a difficult investment climate as well as attracting interest from potential investors to one of the top level industries in the world, this has become a meaningful success story made possible by the organic cooperation with HunetPlus executives.” Cho Namhoon, CEO of K-Ground Ventures, an existing investor and the operator of Scale-Up TIPS who provided behind-the-scenes support for this investment, said: “Even in Korea’s challenging environment for bold investments in original technology, we had a strong belief in Hunet Plus’ global-standard R&D capabilities. Through the Hongneung Advanced Science & Technology Commercialization Fund, we took the bold step of making an early-stage investment, followed by support for subsequent fundraising, reinvestment through the Innovation IP Fund, and additional backing via Scale-Up TIPS. This long-term investment strategy has brought significant results. In particular, the attracting investment from renowned global investors is expected to support U.S. market entry and lead to further follow-on investments, ultimately building a sustainable global supply ecosystem for Korean semiconductor technology through joint Korea–U.S. R&D, production, and marketing.” Meanwhile, on August 6 (local time), U.S. President Donald Trump, at an Apple facility investment announcement event, stated, “We will impose 100% tariffs on every semiconductor imported into the United States.” This announcement has drawn intense attention from semiconductor startups and investors, as semiconductors are the second-largest category of U.S.-bound exports, especially ahead of the upcoming Korea–U.S. summit, where the government’s response will be closely watched. Media contact Brand: Hunet Plus Contact: Hyukjin Cha, CEO Email: support@hunetplus.com Telephone: +82-10-8817-0003 Website: https://en.hunetplus.com

Kuala Lumpur, August 2025 — As the global wave of financial digitalization accelerates, traditional insurance is undergoing profound transformation. LIVI NeoAsia (hereinafter "LV.onl") today officially launched an innovative model that deeply integrates "digital asset accounts + statutory insurance coverage," redefining the essence of insurance: It is not merely a consumption expense but a financial instrument for precise risk transfer. More critically, it serves as a central nexus connecting "life protection, asset appreciation, and risk hedging." Debunking Misconceptions: Insurance as "Actuarial Value," Not "Sunk Cost" Conventionally, insurance is often perceived as a consumption behavior—"paying for peace of mind"—where premiums are deemed "wasted" if no claims occur. LV.onl fundamentally challenges this notion: At its core, insurance represents "precise actuarial value for risk transfer." Premiums paid by users essentially lock in certainty against future risks (e.g., illness, accidents, retirement shortfalls). This value itself can be transformed, through compliant design, into "appreciable, inheritable, and flexibly allocatable" assets. For example, every policy purchased includes not only statutory coverage (e.g., medical, accident protection) but also channels premiums into asset pools managed by licensed institutions. These funds generate steady growth through low-risk instruments like money market funds and bonds, truly achieving "active protection with tangible asset growth." The LV.onl Model: Making "Protection = Wealth Management = Risk Transfer" a Reality LV.onl’s core solution lies in its "Insurance-Anchored Asset Protection System," unifying these three pillars: Insurance as the Value Anchor: All products are underwritten by licensed insurers, covering statutory protections (e.g., health, retirement), ensuring legal validity of risk transfer. Policy terms and claims mechanisms are recorded on the blockchain with tamper-proof immutability, providing users full transparency into "risk coverage scope." Stablecoin as the Circulation Vehicle: The compliant stablecoin Cloud Token, pegged to real-world fiat assets, strictly adheres to Hong Kong’s 2025 Stablecoin Act. It operates exclusively in closed-loop scenarios (e.g., premium payments, policy upgrades), eliminating speculative risks while enhancing asset liquidity. Digital Account as the Management Hub: Users automatically receive a LIVI Vault digital account, displaying real-time premium allocation, asset returns, and coverage status. The account enables "goal-based allocation," allowing customized plans (e.g., children’s education, retirement reserves), deeply integrating risk transfer with life planning. Focus on Southeast Asia: Bridging the "Protection Gap" for 600 Million People LV.onl’s model holds particular significance in Southeast Asia—a region with low insurance penetration yet high digital payment adoption. Among its 600 million people, many remain unprotected due to complex traditional insurance processes and poor cost-performance ratios. LV.onl simplifies onboarding and introduces community incentives (e.g., stablecoin rewards for referrals), enabling broader access to dual-value "protection + wealth management" at low cost. As stated by LV.onl’s team: "We are not selling insurance; we are building an infrastructure that empowers everyone to master risk and accumulate wealth." With upcoming approvals for Hong Kong’s stablecoin license and Southeast Asian insurance qualifications, this model is poised to become a new bridge connecting the digital economy and social safeguards.

London, Suku Ketiga 2025 — Dalam gelombang transformasi digital kewangan global, industri insurans sedang mengalami peningkatan paradigma daripada "perlindungan risiko tunggal" kepada "perlindungan aset komprehensif". LIVI NeoAsia Group Ltd (atau "LV.onl") memperkenalkan sistem inovatif "Perlindungan Aset Berjangkar Insurans", mentakrifkan semula logik perlindungan era digital. Insurans bukan sekadar "jaring keselamatan" risiko, malah menjadi "penstabil" penghargaan aset. Berakar pada Pematuhan: Tiga Kerangka Kukuh Membina Asas Kepercayaan Keunggulan kompetitif LV.onl berpunca daripada komitmen mendalam terhadap pematuhan. Sebagai platform berdaftar di UK, operasinya mematuhi ketat keperluan kawal selia pelbagai wilayah: Di Asia Tenggara, bekerjasama dengan syarikat insurans berlesen tempatan di Malaysia dan Indonesia bagi membangunkan produk, memastikan semua polisi mematuhi peraturan insurans tempatan. Pada peringkat aset digital, stablecoin Cloud Token-nya selaras sepenuhnya dengan Akta Stablecoin Hong Kong berkuat kuasa 1 Ogos 2025, dijangkar pada kolam aset insurans sebenar tanpa ICO atau dagangan awam, digunakan semata-mata untuk pembayaran dan penyelesaian dalam ekosistem kontrak insurans tertutup, mengelak risiko spekulasi dari akar umbi. Struktur "Penyelarasan Ibu Pejabat UK + Operasi Tempatan Asia Tenggara + Penjangkaran Pematuhan Hong Kong" ini menjadikannya platform pertama mencapai "Akaun Insurans Web3 Diiktiraf Kawal Selia", menjamin setiap perlindungan pengguna berlandaskan undang-undang dan boleh diaudit. Inovasi Produk: Daripada "Polisi Penggunaan" kepada "Aset Digital Berkembang" Kelemahan insurans tradisional ialah "perbelanjaan sehala" dan "kekaburan maklumat" — pengguna sukar menjejaki aliran dana selepas bayaran, apatah lagi menikmati penghargaan aset. LV.onl mengatasi halangan ini melalui sistem akaun digital LIVI Vault: Selepas membeli insurans, premium pengguna diagihkan secara automatik mengikut kontrak ke kolam aset diurus pasukan profesional, dilabur dalam instrumen patuh seperti dana pasaran wang dan bon, dengan pulangan dikreditkan berkala ke akaun. Akaun memaparkan status perlindungan, hak dividen dan pegangan Cloud Token secara masa nyata, menjadikan "perlindungan" dan "penghargaan" boleh dilihat dan dikawal. Contohnya, polisi dengan perlindungan kesihatan bukan sahaja membiayai perubatan ketika sakit, tetapi pulangan pelaburan premiumnya boleh digunakan untuk pembaharuan premium masa depan atau perbelanjaan kecemasan keluarga, mencapai "satu pelaburan, pelbagai nilai". Susunan Ekosistem: Membawa "Perlindungan Bersuhu" kepada 600 Juta Rakyat Asia Tenggara Asia Tenggara mempunyai 600 juta penduduk, tetapi menghadapi masalah kadar penembusan insurans rendah dan produk tidak pelbagai. LV.onl memperkenalkan produk ringkas dan modular: Pengguna boleh memilih pakej seperti "Simpanan Pendidikan + Perubatan Kanak-kanak" atau "Perancangan Persaraan + Perlindungan Penyakit Kritikal" mengikut fasa hidup, melengkapkan proses insurans/tuntutan melalui telefon. Platform menggalak pengguna menyertai pembangunan ekosistem — menjemput rakan memperoleh ganjaran Cloud Token untuk meningkatkan had perlindungan atau buka perkhidmatan eksklusif, mengubah insurans daripada "pembelian pasif" kepada "penyertaan aktif". Pasukan LV.onl menyatakan: "Matlamat kami bukan menggantikan insurans tradisional, tetapi mendekatkan insurans kepada keperluan rakyat biasa melalui teknologi — apabila perlindungan berkembang bersama hidup, apabila aset menjadi penyangga risiko, barulah insurans menjadi 'pemberat kekayaan' sebenar keluarga." Difahamkan, platform telah melengkapkan pengesahan pengguna sulung di Malaysia, merancang kembangkan ke Indonesia, Filipina dll pada 2026, serta memulakan permohonan lesen stablecoin dan perantaraan insurans di Hong Kong, terus menyempurnakan ekosistem "Insurans + Aset + Teknologi".

SHENZHEN, CHINA, Aug 19, 2025 – (ACN Newswire via SeaPRwire.com) – On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. During the Reporting Period, the Company recorded revenue of approximately RMB4.00 billion, representing a year-on-year increase of 10.8%. In the case that all medicines were directly sold by the Company, revenue would be approximately RMB4.67 billion, up 8.9% year-on-year. Net profit was approximately RMB0.93 billion, representing an increase of 3.1% year-on-year. The results reflect that CMS has emerged from the shadow of National Volume-based Procurement (“National VBP”), and its performance is expected to return to a sustainable growth trajectory. Revenue from the Company’s key non-National VBP exclusive/branded products and innovative products (in the case that all medicines were directly sold by the Company) reached approximately RMB2.90 billion, up 20.6% year-on-year, accounting for 62.1% of total revenue. The company’s exclusive/branded products and innovative products have a favorable competitive landscape and high visibility of future growth, and have now become the main drivers of performance growth. According to the interim results announcement, the company has been planning its “New CMS” blueprint since 2018, anchored on the three strategic pillars of “product innovation, commercial model reform, and international expansion” to build a sustainable second growth curve. By the first half of 2025, solid operating results and the steady delivery of innovation outcomes have confirmed that the Company’s strategic upgrade has been gradually translated into tangible achievements. “New Products” Strategy Drives Innovation Value Realization and Solidifies Growth Momentum At the forefront of the Company’s three strategic pillars, the “product innovation” strategy leverages a three-dimensional innovation mechanism of “overseas licensing, domestic collaboration, and in-house R&D” to continuously inject high-value short-, medium- and long-term pipelines, serving as a key growth engine. Currently, the innovation strategy has entered a period of continuous harvest, with new products continuously releasing commercial and clinical value. To date, the Company has successfully commercialized five innovative drugs in China; By 2025, two innovative products — ruxolitinib cream and Desidustat Tablets—are also expected to receive marketing approvals. Ruxolitinib cream is the first and only topical JAK inhibitor approved by the U.S. FDA and the European Medicines Agency for repigmentation in non-segmental vitiligo, and is expected to become the first approved treatment for vitiligo in China, filling a market gap and bringing new hope to Chinese vitiligo patients. Additionally, the New Drug Application (NDA) for the Alzheimer’s disease drug ZUNVEYL in China was accepted in July this year; the consumer healthcare product Poly-L-lactic Acid Microparticle Filler Injection has been approved for marketing, further enriching the Company’s diversified product portfolio. Among the innovative pipeline under R&D, several blockbuster candidates have entered the late-stage clinical development in China and are expected to be commercialized within the next one to three years, forming a new driving force for sustained growth. Among these, the collaborative product Y-3 for Injection has completed Phase III clinical trials in China. This product is an original unimolecular Class 1 innovative drug and the only non-peptide PSD95/nNOS uncoupler that has entered clinical development, with potential to become the first dual-function brain cytoprotectant for treating ischemic stroke while preventing post-stroke depression and anxiety. Another oral small molecule Class 1 innovative drug, ABP-671 (a URAT1 inhibitor) for the treatment of gout and hyperuricemia, is progressing through Phase IIb/III clinical trials in China. Compared with existing mainstream drugs, ABP-671 has the potential to reduce uric acid to lower levels at lower doses and possesses gout-tophus dissolution capability, thereby offering patients a more effective and safer treatment option. CMS continues to expand its innovative pipeline and enhance its end-to-end innovation capabilities to ensure the steady, phased marketing approval of innovative products. In H1 2025, two new collaborative R&D innovative products — ZUNVEYL and MG-K10 (a long-acting anti-IL-4Rα humanized monoclonal antibody injection) — were added to the portfolio. To date, the Company has deployed about 40 differentiated innovative pipeline products, including approximately 20 in-house R&D projects. Advancing “New Models” and “New Markets” Strategies to Unlock Multi-dimensional Growth According to the interim results announcement, CMS continues to advance its “New Models — Commercial Model Reform” strategy, forging anti-cyclical resilience through a diversified ecosystem. It also firmly implements its “New Markets – International Expansion” strategy, building a multi-dimensional growth framework via an industrial internationalization model. Under the commercial model reform strategy, the Company continues to focus on specialty therapeutic fields while expanding into new retail and new media channels, building a comprehensive marketing and promotion system that covers both “in-hospital + out-of-hospital” and “online + offline” channels, and reinforcing its diversified product portfolio with consumer attributes. Its skin health business, Dermavon, has demonstrated strong potential in this particular segment with consumer attributes. Since its independent operation in 2021, Dermavon has achieved dual leadership in both the “coverage of dermatology indications” and the “revenue scale of dermatological prescription drugs”, and is proposed to be spun off and separately listed on the Main Board of the Hong Kong Stock Exchange by way of introduction and distribution in specie, to further unlock its standalone value and high-growth potential. In terms of internationalization, CMS successfully completed its secondary listing on the Main Board of the Singapore Exchange by way of introduction on 15 July 2025, marking a new milestone in its “industrial internationalization” strategy. With Singapore as a hub, the Company has established a comprehensive business system covering the entire value chain of “R&D–Manufacturing–Commercialization” for emerging markets. To date, its commercial platform company, Rxilient, has cumulatively submitted nearly 20 registration applications for pharmaceutical products and medical devices across Southeast Asia, the Middle East, Hong Kong, Macau, and Taiwan Region, covering therapeutic fields such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system. Ruxolitinib cream (vitiligo indication) has been approved for marketing in Macau and Hong Kong, and its registration applications have been submitted in Singapore and Taiwan Region. Intravenous Toripalimab (the first China-originated anti-PD-1 monoclonal antibody drug that has been approved by the China NMPA and the U.S. FDA) has been submitted for registration in five countries, including Malaysia. Tildrakizumab Injection and Sucroferric Oxyhydroxide Chewable Tablets have also been approved for marketing in Hong Kong. Meanwhile, PharmaGend, an associate CDMO manufacturing facility in which CMS holds a 45.0% equity interest, now has an annual production capacity of 1 billion units of oral solid dosage forms (tablets and capsules), and has obtained a drug manufacturing license from Singapore’s HSA, U.S. FDA cGMP certification, and passed Swiss QP audits. The construction of new production lines for nasal sprays, creams, and injectables is progressing steadily, providing high-standard production and delivery capabilities for the international market. Looking ahead, the growth logic of “New CMS” is expected to accelerate its realization, with profitability and performance resilience improving simultaneously. The Company is building a growth framework centered on differentiated innovation, driven by a synergistic and diversified ecosystem, and underpinned by an international footprint. This will open up long-term opportunities for high-quality development, deliver quality pharmaceutical products and services to patients worldwide, and generate sustainable returns for shareholders. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/ skin health businesses. Among them, the skin health business has become a leading enterprise in its field, bringing economies of scale in specialty therapeutic fields. Meanwhile, CMS continuously deepens its business development in the Southeast Asia and Middle East regions, further escorting the sustainable and healthy development. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com Categories: ACN Newswire

Linyi, Shandong, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors. Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials. The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures. Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry. Media ContactCompany: Beijing Jinyi Youlian Exhibition Co., Ltd.Contact Person: VincyTel: 86-10-63356966Fax: 86-10-63356950Address: 9th Floor, Fortune West Plaza, 58 Caihuying, Fengtai District, Beijing, 100054, ChinaEmail: hardwarefair@163.comWebsite: https://www.hardware-fair.com/p/EN.htmlhttps://www.qjwjh.com/p/EN.html Copyright 2025 ACN Newswire via SeaPRwire.com.

EMI GROUP LIMITED secara rasmi memperkenalkan platform digital baharu EMI APP, yang direka untuk memperbaharui kaedah penyebaran muzik melalui mekanisme inovatif dan sumber global. Platform ini bertujuan untuk membina ekosistem muzik digital yang terbuka, saling berhubung dan mampan untuk pencipta, pendengar serta rakan industri. Dengan sokongan pengaruh antarabangsa daripada syarikat induk, Universal Music Group, EMI APP menggabungkan promosi muzik dengan nilai komersial, memacu industri muzik global ke tahap baharu. Sejak ditubuhkan pada tahun 1928, EMI GROUP LIMITED telah menjadi pemacu utama budaya muzik global. Dari era cakera padat tradisional ke muzik digital, EMI bukan sahaja menyaksikan perubahan industri, malah kerap menjadi peneraju trend. Kini, EMI melalui EMI APP menghubungkan keseluruhan rantaian daripada penciptaan, promosi hingga pengewangan, memberikan tenaga baharu kepada industri muzik global. Sumber Kandungan Global Menghubungkan Pencipta dan Pasaran EMI APP menghimpunkan sumber berkualiti tinggi daripada gergasi muzik antarabangsa seperti Universal Music Group, Sony Music Entertainment dan Warner Music Group, serta menggabungkan kandungan daripada label terkemuka termasuk Columbia, Virgin, A&M dan Rose Records. Melalui rangkaian kerjasama global ini, platform ini menawarkan perpustakaan muzik berkualiti tinggi yang membolehkan artis menembusi pasaran antarabangsa dan memberikan pengalaman mendengar yang pelbagai kepada pengguna. Mekanisme Pemacu Tugas Mengaktifkan Penyertaan Semua Platform ini menggunakan model “Pemacu Tugas + Pembahagian Keuntungan”. Syarikat muzik dan penerbit boleh menyiarkan tugasan promosi, dan pengguna global boleh mengambil bahagian melalui penstriman, perkongsian serta interaksi, sambil menerima ganjaran berdasarkan sumbangan mereka. Mekanisme ini memecahkan halangan promosi tradisional, menggabungkan “penghayatan” dengan “penciptaan nilai”, sekali gus memberi kuasa kepada artis dan pengguna. Pemerkasaan Teknologi untuk Promosi Tepat Sasaran EMI APP terus meningkatkan teknologinya dengan mengaplikasikan cadangan berasaskan AI, analisis tingkah laku pengguna dan penilaian keberkesanan, bagi memastikan muzik sampai kepada khalayak sasaran dengan tepat serta mengoptimumkan pembahagian keuntungan. Pada masa yang sama, platform ini meneroka bidang termaju seperti Web3, NFT dan pengesahan hak milik aset muzik, untuk mempelbagaikan cara nilai aset muzik digital disampaikan. Misi Pelbagai Dimensi, Membina Ekosistem Muzik yang Saling Bergantung Misi EMI APP bukan sekadar membina platform promosi muzik yang cekap, tetapi untuk menghubungkan pencipta, pendengar dan rakan industri di seluruh dunia. Ia membuka laluan terus ke pasaran antarabangsa untuk artis, membolehkan karya mereka tersebar luas dan bernilai; memberi pengguna pengalaman daripada penghayatan kepada penyertaan, di mana mereka boleh membantu penyebaran muzik sambil berkongsi ganjaran; serta mendorong penambahbaikan struktur industri melalui inovasi teknologi dan model, mempercepatkan hubungan dan kerjasama dalam ekosistem muzik global. Prospek Masa Depan Dalam era di mana ekonomi digital dan industri kreatif budaya semakin bersepadu, EMI APP bukan sahaja mencerminkan transformasi inovatif EMI Group, malah menjadi titik penting perkembangan industri muzik global ke arah “Pemfungsian Platform + Penyertaan + Pemacuan Nilai”. Platform ini akan terus memperluas rangkaian kerjasama, meningkatkan keupayaan teknologi, mengoptimumkan pengalaman pengguna, dan membina pentas bersama yang menggabungkan makna budaya serta kekuatan komersial untuk artis, pengguna dan rakan industri di seluruh dunia, sambil melangkah maju dengan keyakinan memimpin industri ke hadapan.

EMI GROUP LIMITED has officially launched the EMI App, a new digital platform. Leveraging innovative mechanisms and global resources, the platform aims to reshape music distribution and build an open, connected, and sustainable digital music ecosystem for creators, listeners, and industry partners. Leveraging the international influence of its parent company, Universal Music Group, the EMI App deeply integrates music promotion and commercial value, propelling the global music industry into a new era. Since its founding in 1928, EMI Group Limited has been a vital driving force in global music culture. From traditional records to digital music, EMI has not only witnessed the industry's transformation but has also repeatedly set trends. Today, through the EMI App, EMI connects the entire process from creation, promotion, to monetization, injecting new momentum into the global music industry. Global content resources connect creation and the market The EMI App aggregates premium resources from international record giants like Universal Music Group, Sony Music Entertainment, and Warner Music Group, and integrates content from leading labels like Columbia, Virgin, A&M, and Rose. Leveraging this global network, the platform boasts a vast library of high-quality music, allowing musicians to directly access the international market and providing users with a diverse listening experience. A task-driven mechanism activates universal participation The platform adopts a "task-driven + revenue sharing" model. Music companies and producers can publish promotional tasks, and users worldwide can participate through playback, sharing, and interaction, earning revenue proportional to their contributions. This mechanism breaks through the bottleneck of traditional promotion, organically combining "appreciation" with "value creation," empowering both creators and users. Technology-Enabled Precision Promotion The EMI App continues to upgrade its technology, applying AI-powered recommendations, user behavior analysis, and quantitative performance evaluation to ensure music reaches its target audience and optimize revenue distribution. Furthermore, the platform is exploring cutting-edge areas such as Web3, NFTs, and music asset ownership, promoting the diversified value expression of digital music assets. A multi-faceted mission: building an interconnected and symbiotic music ecosystem The EMI App's mission is not only to create an efficient music promotion platform, but also to connect global creators, listeners, and industry partners. The platform opens a channel for musicians to enter the international market, allowing their works to continue to spread and realize their value among diverse audiences. It provides users with an experience from appreciation to participation, allowing them to contribute to the spread of music and share in the rewards through interaction. Furthermore, it promotes industry structure optimization through technological and model innovation, accelerating the interconnection and symbiosis of the global music ecosystem. Future Outlook Against the backdrop of the deep integration of the digital economy and the cultural and creative industries, the EMI App is not only a key manifestation of EMI Group's innovative transformation, but also a key milestone in the music industry's evolution towards a "platform + participation + value" model. The platform will continue to expand its partnerships, enhance its technical capabilities, and optimize the user experience, creating a shared platform with both cultural significance and commercial power for musicians, users, and industry partners worldwide, and leading the industry forward with unwavering determination.

Seiring dengan perkembangan pesat pasaran aset digital global, AMG Exchange, melalui model operasi yang mematuhi peraturan serta sokongan teknologi yang kukuh, semakin mengukuhkan kedudukannya sebagai platform dagangan aset digital yang dipercayai pengguna di seluruh dunia. Sebagai sebuah bursa yang berdaftar secara sah dan memiliki lesen kewangan mata wang digital di pelbagai negara, AMG sentiasa berpegang pada prinsip teras “Pengguna Diutamakan, Keselamatan Sebagai Asas”. Syarikat ini mematuhi sepenuhnya keperluan pengawalseliaan di setiap wilayah operasi, memastikan keselamatan dana dan data pengguna. Sehingga kini, AMG telah menyediakan perkhidmatan dagangan yang stabil dan berkesan kepada lebih 5 juta pengguna, dengan jumlah dagangan yang terus mencatat pertumbuhan. Jurucakap AMG Exchange berkata: “Kami sedar sepenuhnya cabaran keselamatan yang dihadapi industri aset digital. Oleh itu, kami terus melabur dalam peningkatan keselamatan sistem, proses semakan pengurusan risiko, dan mekanisme anti–pengubahan wang haram, demi menyediakan persekitaran dagangan yang adil, telus, dan stabil untuk para pengguna.” Melangkah ke hadapan, AMG akan terus memperluaskan pasaran global serta merancang untuk melancarkan lebih banyak saluran fiat dan produk kewangan inovatif dalam tahun ini, bagi memperkayakan pengalaman dagangan aset digital pengguna. Pada masa yang sama, AMG akan terus melaksanakan tanggungjawab sosial korporatnya dengan menyertai pelbagai aktiviti kebajikan dan amal, sekali gus menyokong pembangunan mampan masyarakat. Mengenai AMG Exchange AMG Exchange ialah platform dagangan aset digital terkemuka di peringkat global yang berdedikasi untuk menyediakan perkhidmatan dagangan mata wang kripto yang selamat, mudah, dan inovatif kepada pengguna di seluruh dunia. Platform ini menyokong pelbagai dagangan mata wang kripto utama, disokong oleh pasukan teknikal yang berkemahiran tinggi serta sistem pematuhan yang mantap, dengan keutamaan mutlak terhadap keselamatan aset pengguna dan pengalaman dagangan yang unggul.

Los Angeles, CA – August 10, 2025 – (SeaPRwire) – The Intervision’25 International Music Contest is set to take place in Moscow on September 20th, 2025, promising a high-profile celebration of global musical talent. In connection with the event, there is growing buzz suggesting that a descendant of Michael Jackson may be among the participants, though this remains unconfirmed. The 2025 edition is expected to offer a high-quality production with elaborate stage designs and will likely attract significant media attention. And it is expected to host artists from more than 20 countries, each presenting a musical style that reflects their culture. Choosing a representative tied to a legendary musical legacy could be a strategic move to capture the attention of global audiences. Michael Jackson’s connection to Russia is well-documented, as he performed twice in Moscow. His first visit was in 1993 as part of his Dangerous World Tour, followed by a second performance in 1996 during his HIStory World Tour. His popularity in Russia, alongside the potential participation of a Jackson family member in a prominent international event, is already generating buzz among music fans and industry insiders. While the identity of the potential performer remains unconfirmed, there is speculation that it may be one of the younger generation of Jacksons, who have already started to carve out careers in the entertainment industry. In recent years, the music industry has increasingly embraced younger artists who not only carry the torch of past icons but also bring fresh perspectives and modern sensibilities to their craft. This blend of legacy and innovation is particularly fitting for Intervision, where diverse musical expressions converge. By choosing a descendant of Michael Jackson, the U.S. could showcase how its musical heritage inspires contemporary artistry and resonates across generations. About Intervision Intervision is an international music competition that originated in the late 1970s, serving as a counterpart to Eurovision for countries in Eastern Europe, the Soviet Union, and parts of Asia. The event was initially aimed at fostering cultural exchange and showcasing musical diversity that was less influenced by Western pop trends. After a long hiatus, the competition was revived in the 21st century, now attracting global artists to participate. Social Links Telegram: https://t.me/intervision_world VK: https://vk.com/intervision.world OK: https://ok.ru/group/70000037652397 Rutube: https://rutube.ru/channel/64873781/ TikTok: https://www.tiktok.com/@intervision.world YouTube: https://www.youtube.com/@intervisionworld.official X: https://x.com/intervisionwld?s=11 Media contact Brand: Intervision’25 International Music Contest Contact: PR team Email: media@intervision.world Website: https://intervision.world/en/

Los Angeles, CA – August 10, 2025 – (SeaPRwire) – The Intervision’25 International Music Contest is set to take place in Moscow on September 20th, 2025, promising a high-profile celebration of global musical talent. In connection with the event, there is growing buzz suggesting that a descendant of Michael Jackson may be among the participants, though this remains unconfirmed. The 2025 edition is expected to offer a high-quality production with elaborate stage designs and will likely attract significant media attention. And it is expected to host artists from more than 20 countries, each presenting a musical style that reflects their culture. Choosing a representative tied to a legendary musical legacy could be a strategic move to capture the attention of global audiences. Michael Jackson’s connection to Russia is well-documented, as he performed twice in Moscow. His first visit was in 1993 as part of his Dangerous World Tour, followed by a second performance in 1996 during his HIStory World Tour. His popularity in Russia, alongside the potential participation of a Jackson family member in a prominent international event, is already generating buzz among music fans and industry insiders. While the identity of the potential performer remains unconfirmed, there is speculation that it may be one of the younger generation of Jacksons, who have already started to carve out careers in the entertainment industry. In recent years, the music industry has increasingly embraced younger artists who not only carry the torch of past icons but also bring fresh perspectives and modern sensibilities to their craft. This blend of legacy and innovation is particularly fitting for Intervision, where diverse musical expressions converge. By choosing a descendant of Michael Jackson, the U.S. could showcase how its musical heritage inspires contemporary artistry and resonates across generations. About Intervision Intervision is an international music competition that originated in the late 1970s, serving as a counterpart to Eurovision for countries in Eastern Europe, the Soviet Union, and parts of Asia. The event was initially aimed at fostering cultural exchange and showcasing musical diversity that was less influenced by Western pop trends. After a long hiatus, the competition was revived in the 21st century, now attracting global artists to participate. Social Links Telegram: https://t.me/intervision_world VK: https://vk.com/intervision.world OK: https://ok.ru/group/70000037652397 Rutube: https://rutube.ru/channel/64873781/ TikTok: https://www.tiktok.com/@intervision.world YouTube: https://www.youtube.com/@intervisionworld.official X: https://x.com/intervisionwld?s=11 Media contact Brand: Intervision’25 International Music Contest Contact: PR team Email: media@intervision.world Website: https://intervision.world/en/

August 09, 2025 - (SeaPRwire) - Dexlevo announced that it successfully concluded its participation in the international conference “AMSC 2025 (Aesthetic Medicine & Surgery Conference),” held in Malaysia from August 6 to 7, by operating lectures and an exhibition booth based on the technology and latest clinical cases of its flagship product GOURI. AMSC is an international academic event in which aesthetic medicine experts from Asia and around the world participate, serving as an authoritative platform for global medical professionals to share knowledge and trends through lectures and brand exhibitions. Through its participation in this event, Dexlevo focused on further enhancing the global recognition of GOURI and directly introducing to medical professionals the differentiated technology of the liquid-type PCL-based collagen stimulator. During the event period, Dexlevo operated a brand booth introducing GOURI’s proprietary technology and clinical strengths, and increased understanding of the product through practical communication with on-site medical professionals. In particular, GOURI’s global Key Opinion Leader (KOL), Dr. Jason Yip, took the stage as a speaker and presented on the structural characteristics and clinical benefits of liquid PCL (polycaprolactone). He highlighted GOURI’s uniform diffusion within tissue, excellent biocompatibility, and collagen-stimulating mechanism, focusing on the technological advancements that overcome the limitations of existing products. GOURI is the world’s first liquid-type PCL-based collagen stimulator, developed using Dexlevo’s proprietary CESABP (Collagen-Enhanced Spreading and Absorption Based Polymerization) technology. It currently holds CE certification in Europe and is distributed in more than 45 countries worldwide, rapidly expanding its presence in the global market. A Dexlevo representative said, “AMSC 2025 was a meaningful opportunity to directly share GOURI’s technology and clinical effects with global medical professionals, and to hear vivid feedback. In the future, we will continue to strengthen GOURI’s international credibility and brand value through ongoing academic activities and clinical exchanges.” Contact Information Brand: Dexlevo Contact: Nicole Kim Email: nicole.kim@dexlevo.com